ABOUT THIS STUDY
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
Pfizer Clinical Trials Contact Center
1-800-718-1021
- Previously participated in an eligible Exubera clinical trial
- Willing to provide study doctor with at least one alternate contact person
- Participated in an investigational study of an unapproved drug since completing the
Exubera trial
- Ever used an other (non-Exubera) inhaled insulin
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Pittsburgh, Pennsylvania
- Bay Minette, Alabama
- Fairhope, Alabama
- Graysville, Alabama
- Pell City, Alabama
- Phoenix, Arizona
- Phoenix, Arizona
- Phoenix, Arizona
- Forrest City, Arkansas
- Searcy, Arkansas
- Cudahy, California
- El Cajon, California
- Huntington Beach, California
- Rolling Hills Estates, California
- San Jose, California
- Santa Ana, California
- Westminster, California
- Denver, Colorado
- Milford, Connecticut
- Wilmington, Delaware
- Boca Raton, Florida
- Clearwater, Florida
- Debary, Florida
- Gainesville, Florida
- Green Cove Springs, Florida
- Hollywood, Florida
- Kissimmee, Florida
- Kissimmee, Florida
- Marianna, Florida
- Merritt Island, Florida
- Miami, Florida
- Niceville, Florida
- Opa Locka, Florida
- Orange City, Florida
- Ormond Beach, Florida
- Pembroke Pines, Florida
- Plantation, Florida
- Port Charlotte, Florida
- Tampa, Florida
- Tampa, Florida
- Atlanta, Georgia
- Atlanta, Georgia
- Conyers, Georgia
- Decatur, Georgia
- Warner Robins, Georgia
- Boise, Idaho
- Greenville, Illinois
- Libertyville, Illinois
- Fishers, Indiana
- Indianapolis, Indiana
- Indianapolis, Indiana
- Des Moines, Iowa
- Louisville, Kentucky
- Mount Sterling, Kentucky
- Bossier City, Louisiana
- Auburn, Maine
- Baltimore, Maryland
- Elkton, Maryland
- Glen Burnie, Maryland
- Wheaton, Maryland
- Boston, Massachusetts
- Plymouth, Massachusetts
- Ann Arbor, Michigan
- Battle Creek, Michigan
- Battle Creek, Michigan
- Clinton, Michigan
- Flint, Michigan
- Muskegon, Michigan
- Sterling Heights, Michigan
- Troy, Michigan
- Warren, Michigan
- Saint Cloud, Minnesota
- Grand Island, Nebraska
- Incline Village, Nevada
- Belleville, New Jersey
- Belvidere, New Jersey
- Glendora, New Jersey
- Albuquerque, New Mexico
- Babylon, New York
- Brooklyn, New York
- New Hartford, New York
- Rochester, New York
- Williamsville, New York
- Asheboro, North Carolina
- Charlotte, North Carolina
- Morehead City, North Carolina
- Raleigh, North Carolina
- Raleigh, North Carolina
- Shelby, North Carolina
- Tabor City, North Carolina
- Winston-Salem, North Carolina
- Bismarck, North Dakota
- Ashtabula, Ohio
- Canton, Ohio
- Cleveland, Ohio
- Columbus, Ohio
- Dayton, Ohio
- McConnelsville, Ohio
- Zanesville, Ohio
- Clinton, Oklahoma
- Bend, Oregon
- Broomall, Pennsylvania
- Dauphin, Pennsylvania
- Fogelsville, Pennsylvania
- Hanover, Pennsylvania
- Harrisburg, Pennsylvania
- Jeannette, Pennsylvania
- Jenkintown, Pennsylvania
- Jersey Shore, Pennsylvania
- Norristown, Pennsylvania
- Philadelphia, Pennsylvania
- Plymouth Meeting, Pennsylvania
- Tipton, Pennsylvania
- Charleston, South Carolina
- Florence, South Carolina
- Greer, South Carolina
- North Myrtle Beach, South Carolina
- Germantown, Tennessee
- Corpus Christi, Texas
- Garland, Texas
- Hurst, Texas
- Kaufman, Texas
- Lubbock, Texas
- Midland, Texas
- San Antonio, Texas
- San Marcos, Texas
- Stephenville, Texas
- Webster, Texas
- Layton, Utah
- Chesapeake, Virginia
- Ettrick, Virginia
- Burnsville, West Virginia
- Charleston, West Virginia
- Aschaffenburg,
- Bad Doberan,
- Bad Groenenbach,
- Bad Oeynhausen,
- Bad Staffelstein,
- Berlin,
- Berlin,
- Bonn,
- Chemnitz,
- Datteln,
- Dortmund,
- Dortmund,
- Eisenach,
- Emden,
- Essen,
- Esslingen,
- Falkensee,
- Friedberg,
- Fulda,
- Hagen,
- Hamburg,
- Hamburg,
- Hohenmoelsen,
- Jena,
- Koeln,
- Leverkusen,
- Mahlberg,
- Mannheim,
- Markdorf,
- Marl,
- Meissen,
- Muenster,
- Muenster,
- Neuwied,
- Nuernberg,
- Reinfeld,
- Riesa,
- Schluechtern,
- Siegen,
- Suhl,
- Villingen-Schwenningen,
- Wangen I. Allgaeu,
- Wangen,
- Warburg,
- Manati,
- Boras,
- Forshaga,
- Goteborg,
- Lilla Edet,
- Chesterfield, Derbyshire
- Ashford, Middlesex
- Dronfield, Sheffield
- Weybridge, Surrey
- Woking, Surrey
- Rugby, Warwickshire
- Warminster, Wiltshire
- Sheffield, Yorkshire
- Airdrie,
- Bath,
- Bath,
- Birmingham,
- Leicester,
- Newcastle Upon Tyne,
- Newcastle Upon Tyne,
- Westbury,
- Phoenix, Arizona
- Tucson, Arizona
- Fresno, California
- Greenbrae, California
- Los Angeles, California
- Sacramento, California
- San Diego, California
- San Diego, California
- San Luis Obispo, California
- Tustin, California
- Walnut Creek, California
- Denver, Colorado
- Hamden, Connecticut
- Madison, Connecticut
- New Britain, Connecticut
- Waterbury, Connecticut
- Chiefland, Florida
- Clearwater, Florida
- Fort Myers, Florida
- Hollywood, Florida
- Miami, Florida
- Ocala, Florida
- Palm Harbor, Florida
- Tallahassee, Florida
- West Palm Beach, Florida
- Honolulu, Hawaii
- Honolulu, Hawaii
- Chicago, Illinois
- Chicago, Illinois
- Chicago, Illinois
- Springfield, Illinois
- Wilmette, Illinois
- New Orleans, Louisiana
- Bethesda, Maryland
- Boston, Massachusetts
- Ann Arbor, Michigan
- Bloomfield Hills, Michigan
- Plymouth, Michigan
- Royal Oak, Michigan
- Southfield, Michigan
- Chesterfield, Missouri
- St. Louis, Missouri
- Butte, Montana
- Lincoln, Nebraska
- Henderson, Nevada
- Albuquerque, New Mexico
- Albuquerque, New Mexico
- Mineola, New York
- New Hyde Park, New York
- Rochester, New York
- Durham, North Carolina
- Winston-Salem, North Carolina
- Mansfield, Ohio
- Tulsa, Oklahoma
- Warwick, Rhode Island
- Beaumont, Texas
- Beaumont, Texas
- Corpus Christi, Texas
- Corpus Christi, Texas
- Dallas, Texas
- Dallas, Texas
- Dallas, Texas
- Houston, Texas
- Irving, Texas
- San Antonio, Texas
- Burlington, Vermont
- Richmond, Virginia
- Renton, Washington
- Milwaukee, Wisconsin
- Porto Alegre, RS
- Sao Paulo, SP
- Calgary, Alberta
- Calgary, Alberta
- Red Deer, Alberta
- Victoria, British Columbia
- Winnepeg, Manitoba
- Winnipeg, Manitoba
- Halifax, Nova Scotia
- Halifax, Nova Scotia
- London, Ontario
- Ottawa, Ontario
- Toronto, Ontario
- Toronto, Ontario
- Laval, Quebec
- Montreal, Quebec
- Montreal, Quebec
- Saskatoon, Saskatchewan
- Aguas Buenas,
- Anasco,
- Cabo Rojo,
- San Juan,
- San Juan,
- New Haven, Connecticut
Descriptive Information | ||||
---|---|---|---|---|
Brief Title | Follow-Up Study for Exubera | |||
Official Title | An Observational Follow-Up Study Of Patients Previously Enrolled In Exubera Controlled Clinical Trials | |||
Brief Summary | In studies of Exubera in persons with diabetes, lung cancer occurred in a few more people who were taking Exubera than in people who were taking other diabetes medicines. All subjects diagnosed with lung cancer had a history of smoking and the number of lung cancer cases observed fell within the expected range based on population-based data. There is currently not enough information to determine if any of the observed lung cancer cases were related to Exubera use, therefore, the study is being conducted to further investigate whether Exubera use makes the appearance of lung cancer more likely. | |||
Detailed Description | Both retrospective and prospective components All subjects who participated in one of the 17 included Exubera clinical trials will be invited to participate in the current study. | |||
Study Type | Observational | |||
Study Design | Observational Model: Cohort | |||
Target Follow-Up Duration | Not Provided | |||
Biospecimen | Not Provided | |||
Sampling Method | Non-Probability Sample | |||
Study Population | All subjects who participated in a controlled trial of Exubera active within the last five years (17 protocols total) | |||
Condition | Diabetes Mellitus | |||
Intervention |
| |||
Study Groups/Cohorts |
| |||
Publications * | Gatto NM, Koralek DO, Bracken MB, Duggan WT, Lem J, Klioze S, Koch GG, Wise RA, Cohen RB, Jackson NC. Lung Cancer-Related Mortality With Inhaled Insulin or a Comparator: Follow-Up Study of patients previously enrolled in Exubera Controlled Clinical Trials (FUSE) Final Results. Diabetes Care. 2019 Sep;42(9):1708-1715. doi: 10.2337/dc18-2529. Epub 2019 Jul 22. | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | ||||
Recruitment Information | ||||
Recruitment Status | Completed | |||
Actual Enrollment | 7439 | |||
Original Estimated Enrollment | 2400 | |||
Actual Study Completion Date | January 2012 | |||
Actual Primary Completion Date | January 2012 (Final data collection date for primary outcome measure) | |||
Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
| |||
Sex/Gender |
| |||
Ages | 18 Years and older (Adult, Older Adult) | |||
Accepts Healthy Volunteers | No | |||
Contacts | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries | Argentina, Australia, Austria, Belgium, Brazil, Canada, Croatia, Denmark, Estonia, Finland, France, Germany, Greece, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Slovakia, South Africa, Spain, Sweden, United Kingdom, United States | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number | NCT00734591 | |||
Other Study ID Numbers | A2171121 | |||
Has Data Monitoring Committee | No | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement | Not Provided | |||
Responsible Party | Pfizer | |||
Study Sponsor | Pfizer | |||
Collaborators | Not Provided | |||
Investigators |
| |||
PRS Account | Pfizer | |||
Verification Date | September 2012 |